Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Exact Sciences Corp. (NASDAQ: EXAS) closed at $55.59 up 3.89% from its previous closing price of $53.51. In other words, the price has increased by $3.89 from its previous closing price. On the day, 2.7 million shares were traded. EXAS stock price reached its highest trading level at $55.77 during the session, while it also had its lowest trading level at $53.58.
Ratios:
For a deeper understanding of Exact Sciences Corp.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.45 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.82 whereas as Long-Term Debt/Eq ratio is at 0.72.
On December 14, 2023, Guggenheim started tracking the stock assigning a Buy rating and target price of $90.
On December 13, 2023, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $95.Wolfe Research initiated its Outperform rating on December 13, 2023, with a $95 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 01 ’24 when Conroy Kevin T sold 1,155 shares for $60.15 per share. The transaction valued at 69,473 led to the insider holds 1,156,191 shares of the business.
Cunningham Everett sold 136 shares of EXAS for $8,180 on May 01 ’24. The Chief Commercial Officer now owns 47,042 shares after completing the transaction at $60.15 per share. On May 01 ’24, another insider, Elliott Jeffrey Thomas, who serves as the Chief Financial Officer of the company, sold 136 shares for $60.15 each. As a result, the insider received 8,180 and left with 11,795 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXAS now has a Market Capitalization of 10258022400 and an Enterprise Value of 12180659200. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.05 while its Price-to-Book (P/B) ratio in mrq is 3.26. Its current Enterprise Value per Revenue stands at 4.805 whereas that against EBITDA is -112.323.
Stock Price History:
Over the past 52 weeks, EXAS has reached a high of $100.77, while it has fallen to a 52-week low of $52.25. The 50-Day Moving Average of the stock is -12.13%, while the 200-Day Moving Average is calculated to be -18.54%.
Shares Statistics:
For the past three months, EXAS has traded an average of 2.72M shares per day and 3565820 over the past ten days. A total of 184.53M shares are outstanding, with a floating share count of 182.61M. Insiders hold about 1.04% of the company’s shares, while institutions hold 82.73% stake in the company. Shares short for EXAS as of 1714435200 were 8876441 with a Short Ratio of 3.27, compared to 1711584000 on 6339844. Therefore, it implies a Short% of Shares Outstanding of 8876441 and a Short% of Float of 4.8699997.
